Tech Company Financing Transactions
SRTD biotech Funding Round
Boehringer Ingelheim Venture Fund, Mérieux Equity Partners and NRW.BANK joined a $34.5 million Seed venture round for SRTD biotech. The round was announced on 11/9/2026.
Transaction Overview
Boehringer Ingelheim Venture Fund (Lead Investor)
Mérieux Equity Partners (Lead Investor)
NRW.BANK (Lead Investor)
Company Information
Jülich, 52428
Germany
Management Team
Browse more venture capital transactions:
Prev: 11/9/2026: Onodrim Industries venture capital transaction
Next: 11/9/2026: Atea Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








